• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Money Profit News
No Result
View All Result
Home Breaking News

BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

by
November 19, 2021
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

Molson Coors and DraftKings team up to let fans bet on ‘high stakes’ Super Bowl ad

3 investing lessons from the Club’s meeting Monday

Medicare users still have time to change, drop 2023 Advantage Plan coverage. What to know

U.S. court rejects J&J bankruptcy strategy for tens of thousands of talc lawsuits

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.

Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

Next Post

Insider buying: Leaders at Uber, Arch Capital bought millions in their own stock this week

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

3 investing lessons from the Club’s meeting Monday

by
January 30, 2023
0

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...

Read more

3 investing lessons from the Club’s meeting Monday

Molson Coors and DraftKings team up to let fans bet on ‘high stakes’ Super Bowl ad

Medicare users still have time to change, drop 2023 Advantage Plan coverage. What to know

U.S. FAA adopts new safeguards after computer outage halted flights

U.S. court rejects J&J bankruptcy strategy for tens of thousands of talc lawsuits

Credit Suisse sees Apple beating the Street this week for a couple reasons

Load More

All rights reserved by www.moneyprofitnews.com

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

moneyprofitnews